StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.39−0.03 (-0.39%)

Close on Nov 17, 2026Market cap $241.88MP/E –Yield –

Lifecore Biomedical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Lifecore Biomedical's pe ratio was 82.6× on Dec 31, 2024, against 14.4× a year earlier. Over the last 5 years it ranged from 13.3× to 82.6×, with a median of 22.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Dec 31, 202482.6×+45.1
2019Jun 28, 201937.5×+23.0
2018Dec 31, 201814.4×−21.6
2017Dec 29, 201736.0×+13.7
2016Mar 31, 201622.3×−0.4
2015Dec 31, 201522.8×+0.8
2014Dec 31, 201421.9×+8.0
2013Dec 31, 201313.9×−2.2
2012Dec 31, 201216.1×−23.3
2011Dec 30, 201139.4×−0.4
2010Dec 31, 201039.9×–

More Lifecore Biomedical figures

See a number that looks wrong?